A robust method for quantification of IKr-related T-wave morphology abnormalities

Computers in Cardiology

Volumn 34, Issue , 2007, Pages 341-344

  Andersen, M P ^a   Xue, J Q ^b   Graff, C ^a   Hardahl, T B ^a   Toft, E ^a,c   Kanters, J K ^c,d   Christiansen, M ^e   Jensen, H K ^f   Struijk, J J ^a  

^a AALBORG UNIVERSITY   (Denmark)

^b GE HEALTHCARE   (United States)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e STATENS SERUM INSTITUT   (Denmark)

^f AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG TESTING; HEALTHY SUBJECTS; MORPHOLOGY CHANGES; ROBUST METHODS; WAVE ASYMMETRIES;

CARDIOLOGY; KRYPTON;

MORPHOLOGY;

EID: 55649112522     PISSN: 02766574     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/CIC.2007.4745491     Document Type: Conference Paper

References (6)

1. Roden DM. Drug-Induced Prolongation of the QT Interval. New England Journal of Medicine. 2004;350(10):1013-22.
2. Yan GX, Antzelevitch C. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome. Circulation. 1998;98(18):1928-36.
3. Kanters JK, Fanoe S, Larsen LA, Bloch Thomsen PE, Toft E, Christiansen M. T wave morphology analysis distinguishes between KvLQT1 and HERG mutations in long QT syndrome. Heart Rhythm. 2004;1(3):285-92.
4. Couderc JP, McNitt S, Xia J, Zareba W, Moss AJ. Repolarization morphology in adult LQT2 carriers with borderline prolonged QTc interval. Heart Rhythm. 2006;3(12):1460-6.
5. Struijk JJ, Kanters JK, Andersen MP, Hardahl T, Graff C, Christiansen M, et al. Classification of the long-QT syndrome based on discriminant analysis of T-wave morphology. Medical and Biological Engineering and Computing. 2006;44(7):543-9.
6. Xue J, Aufderheide T, Scott Wright R, Klein J, Farrell R, Rowlandson I, et al. Added value of new acute coronary syndrome computer algorithm for interpretation of prehospital electrocardiograms. Journal of Electrocardiology. 2004;37(Supplement 1):233-9.